3ZV-17609-02636
5 vaccinations
6 coded responses
26 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 105 / NY
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-01
Dose 1 — Pfizer-BioNTech
-
2021-03-03
Registered in v-safe
- 2021-03-03
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-03-05
- 2021-03-06
- 2021-03-07
-
2021-03-08
Health check-in — day 7, dose 1Feeling: Poor · Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-15
-
2021-03-22
Dose 2 — Pfizer-BioNTech
-
2021-03-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-03-24
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph node under arm where I got the shotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-26
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue, Lymph node pain, Lymphadenopathy — Feeling: Poor · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Very swollen lymph node at the end of my left collarbone near the hollow of my neck. Radiated pain through my entire left shoulder. Accompanied by intense fatigue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-29
-
2021-04-05
Survey response — day 14, dose 2MedDRA: Nausea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Mild somewhat persistent underlying nauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-12
- 2021-04-21
- 2021-04-26
- 2021-05-03
- 2021-06-21
-
2021-08-15
Dose 3 — Pfizer-BioNTech
- 2021-09-20
- 2021-10-02
- 2021-11-16
-
2022-02-13
Survey response — 6 months, dose 3MedDRA: Arteriosclerosis, Cardiac stress test abnormal, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Atherosclerotic heart disease - small abnormality detected on a nuclear stress test · Healthcare visit (other): Nuclear stress test at the hospitalMedDRA releases: 2024-11 · check-in free text available
-
2022-02-13
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-17
Call successfulCompleted over the phone
-
2022-07-10
Dose 4 — Moderna
-
2022-08-15
Survey response — 12 months, dose 3MedDRA: Cardiovascular disorder, Vertigo — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Vertigo and cardiovascular diseaseMedDRA releases: 2024-11 · check-in free text available
-
2022-08-15
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2022-08-16
Call successfulReported to VAERS during previous contact from GDIT
-
2022-11-06
Dose 5 — Pfizer-BioNTech
-
2023-02-05
Survey response — 3 months, dose 5MedDRA: Office visit, Ovarian cyst, Ovarian mass — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-02-05
Report sent to call center — 3 months, dose 5Get care from a doctor or other healthcare professional1 call case(s)
-
2023-02-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-05-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Pfizer-BioNTech | |
| 2 | 2021-03-22 | Pfizer-BioNTech | |
| 3 | 2021-08-15 | Pfizer-BioNTech | No |
| 4 | 2022-07-10 | Moderna | No |
| 5 | 2022-11-06 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
VAERS report filed, before or during a call: 2
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph node under arm where I got the shot
Systemic reaction (other): Very swollen lymph node at the end of my left collarbone near the hollow of my neck. Radiated pain through my entire left shoulder. Accompanied by intense fatigue.
Release 6 — day 14, dose 2
Symptoms: Mild somewhat persistent underlying nausea
Release 11 — 6 months, dose 3
Symptoms: Atherosclerotic heart disease - small abnormality detected on a nuclear stress test
Healthcare visit (other): Nuclear stress test at the hospital
Release 12 — 12 months, dose 3
Symptoms: Vertigo and cardiovascular disease
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Arteriosclerosis | · | · | ✓ |
| SD | Cardiac stress test abnormal | · | · | ✓ |
| SD | Cardiovascular disorder | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Ovarian cyst | · | · | ✓ |
| SD | Ovarian mass | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release